Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival
Authors
Keywords
-
Journal
OncoImmunology
Volume 6, Issue 11, Pages e1358331
Publisher
Informa UK Limited
Online
2017-07-31
DOI
10.1080/2162402x.2017.1358331
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dose-Dependent Induction of an Idiotypic Cascade by Anti-Glycosaminoglycan Monoclonal Antibody in apoE−/− Mice: Association with Atheroprotection
- (2017) Roger Sarduy et al. Frontiers in Immunology
- Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2
- (2016) Nikolai Siebert et al. mAbs
- Arresting progressive atherosclerosis by immunization with an anti-glycosaminoglycan monoclonal antibody in apolipoprotein E-deficient mice
- (2015) Livan Delgado-Roche et al. FREE RADICAL BIOLOGY AND MEDICINE
- Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2immunotherapy and isotretinoin: a prospective Phase II study
- (2015) Brian H Kushner et al. OncoImmunology
- Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18, in children with high-risk neuroblastoma
- (2014) Ami V. Desai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Key role for myeloid cells: Phase II results of anti-GD2antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma
- (2014) Nai-Kong V. Cheung et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma
- (2014) Fariba Navid et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody
- (2014) Yosdel Soto et al. mAbs
- GD2-Targeted Immunotherapy and Radioimmunotherapy
- (2014) Konstantin Dobrenkov et al. SEMINARS IN ONCOLOGY
- Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients
- (2013) Ruth Ladenstein et al. mAbs
- Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission
- (2012) Nai-Kong V. Cheung et al. JOURNAL OF CLINICAL ONCOLOGY
- Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo
- (2012) Nai-Kong V. Cheung et al. OncoImmunology
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pediatric Dosing and Body Size in Biotherapeutics
- (2010) Rong Shi et al. Pharmaceutics
- Phase I and Pharmacokinetic Study of Cetuximab and Irinotecan in Children With Refractory Solid Tumors: A Study of the Pediatric Oncology Experimental Therapeutic Investigators' Consortium
- (2009) Tanya M. Trippett et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: A Children's Oncology Group report
- (2009) Anne L. Angiolillo et al. PEDIATRIC BLOOD & CANCER
- Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study
- (2008) Julia L. Glade Bender et al. JOURNAL OF CLINICAL ONCOLOGY
- Infliximab Treatment of Intravenous Immunoglobulin–Resistant Kawasaki Disease
- (2008) Jane C. Burns et al. JOURNAL OF PEDIATRICS
- Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipients
- (2007) Mark D. Pescovitz et al. PEDIATRIC TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now